PMR Versus MLD on RLS and Sleep Quality in Hemodialysis Patients
Progressive Muscle Relaxation Versus Manual Lymphatic Drainage on Restless Leg Syndrome and Sleep Quality in Hemodialysis Patients
1 other identifier
interventional
120
1 country
1
Brief Summary
Progressive muscle relaxation versus manual lymphatic drainage on restless leg syndrome and sleep quality in hemodialysis patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 15, 2024
CompletedFirst Submitted
Initial submission to the registry
June 25, 2024
CompletedFirst Posted
Study publicly available on registry
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 21, 2024
CompletedJuly 26, 2024
July 1, 2024
3 months
June 25, 2024
July 25, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
International restless legs syndrome rating scale (IRLS)
It consists of 10 questions considering different aspects of the impact of RLS on a patient's life. Each question can be answered with a Likert-type scale ranging from "none" (0) to "very severe" (4).
base line and 12 weeks.
Pittsburgh Sleep Quality Index (PSQI)
It is a self-report questionnaire that assesses sleep quality. The patient asked to rate his/ her sleep quality
base line and 12 weeks
Secondary Outcomes (2)
Leg cramps severity scale
base line and 12 weeks
Patient Health Questionnaire (PHQ-9)
base line and 12 weeks
Study Arms (3)
Group (A):Progressive muscle relaxation (PMR)
EXPERIMENTALpatients receive progressive muscle relaxation (PMR) for 20 minutes after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients
Group (B): Manual lymphatic drainage (MLD)
EXPERIMENTALpatients receive Manual lymphatic drainage (MLD) for 20 minutes within after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients.
Group (C):control
ACTIVE COMPARATORpatients receive routine medical care for dialysis patients. Routine medical care for RLS and sleep quality in hemodialysis Anemia management, electrolyte balance,Avoiding caffeine and alcohol, establishing a regular sleep schedule leg care,Medicines that increase dopamine in the brain, affecting calcium channels, Opioids , Gabapentin and Pregabali , Benzodiazepines
Interventions
patients receive progressive muscle relaxation (PMR) for 20 minutes after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients
Routine medical care for RLS and sleep quality in hemodialysis Anemia management, electrolyte balance,Avoiding caffeine and alcohol, establishing a regular sleep schedule leg care,Medicines that increase dopamine in the brain, affecting calcium channels, Opioids , Gabapentin and Pregabali , Benzodiazepines,Regular monitoring of kidney function, blood tests
Manual lymphatic drainage (MLD) for 20 minutes within after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients
Eligibility Criteria
You may qualify if:
- Male and female adults ranging from 35- 65 years old.
- Able to communicate verbally and agree to participate in the study.
- On maintenance arteriovenous fistula (AVF) hemodialysis 3 times weekly.
- None of the research participants had a lower extremity dialysis graft, and they were all taking medication to maintain their health.
- Prior to the study procedure, all patients underwent a nephrologist assessment
- All patients had good compliance with their dialysis treatment (not missing more than 2 dialysis sessions in the prior 3 months
You may not qualify if:
- Peripheral neuropathy or vascular diseases of the lower limbs.
- Skin diseases including acute psoriasis or eczema.
- Recent fractures or lower limbs surgeries.
- Feet injuries including severe muscle weakness, bruises, ulcers, Open wounds or recent burns
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MTI Universitylead
Study Sites (1)
Ahmed Mohamed Ahmed Abdelhady
Cairo, Egypt
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lectrurer of physical therapy for general surgery and dermatology
Study Record Dates
First Submitted
June 25, 2024
First Posted
July 1, 2024
Study Start
April 15, 2024
Primary Completion
July 20, 2024
Study Completion
July 21, 2024
Last Updated
July 26, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share